Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) changes shares on Friday trading session, with a change of 3.64% or $1.15 shares. The trading starts at $32.72 and closed at $31.58 throughout the day. The trading session low price was $30.83 and day high was $32.79 on Friday, June 12. After the session, the Healthcare sector daily volume shifted to 1.11 million while its average volume is 1.39M. In other hand, the ARWR market cap reached to $3.21B. While, its current target price is $32.73 according to WSJ.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -3.93% and down -4.17% for month. Its quarterly performance was 24.35% above, while its half year performance is down -52.02%. ARWR yearly performance stood at positive 25.26% and fall -48.40% for year-to-date. Current recommendation for Arrowhead Pharmaceuticals Inc. is 2.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. ARWR EPS (TTM) for 12-month is 0.10. EPS for this year is 205.90%, while for the next year its value is -0.97. Sales growth for the current quarter is 45.10 while its EPS Q/Q reached -180.10%. It has an EPS of 20.60% up for past five years and for the next five years will be up 7.33%.
The company posted an EPS (TTM) of 0.10. According to the most recent quarter report on (Jun 2020), 9 analysts estimated an average EPS of -0.11, while 0.21 EPS posted a year ago period. Analyst Estimated EPS for ARWR published in the report was -0.41-0.65 during the same period. Comparing with last year, the average estimated EPS was 0.21 which is higher than -0.2 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for ARWR fall -19.44% for period of 200 days. SMA for 50 days was -4.87% which is showing red signal, while SMA-20 was -5.01%. The moving average value for Arrowhead Pharmaceuticals Inc. (ARWR) is 42.33 and 34.75 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in ARWR stock. On May 12, PERRY MICHAEL S, Director, sold 36,000 trading shares at the cost of $35.83, which valued at 1.29 million. On May 11, Waddill William D., Director, sold 26,000 shares at the cost of $36.54, with total shares of 28,000. On Apr 28, GIVEN BRUCE D, Chief Operating Officer, sold 5,101 shares at the cost of 40.00. After this transaction, GIVEN BRUCE D total shares reached to 850,730 which valued at 0.2 million.